MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 120 filers reported holding MACROGENICS INC in Q4 2017. The put-call ratio across all filers is 0.52 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13 | -100.0% | 2 | -100.0% | 0.00% | – |
| Q3 2022 | $190,000 | +18.0% | 55,163 | +0.6% | 0.00% | – |
| Q2 2022 | $161,000 | -66.1% | 54,811 | +1.5% | 0.00% | – |
| Q1 2022 | $475,000 | -39.4% | 54,021 | +10.5% | 0.00% | – |
| Q4 2021 | $784,000 | -27.7% | 48,872 | -5.6% | 0.00% | -100.0% |
| Q3 2021 | $1,084,000 | -18.0% | 51,780 | +5.1% | 0.00% | 0.0% |
| Q2 2021 | $1,322,000 | -10.3% | 49,245 | +6.4% | 0.00% | 0.0% |
| Q1 2021 | $1,473,000 | -32.1% | 46,282 | -51.3% | 0.00% | 0.0% |
| Q4 2020 | $2,170,000 | +0.7% | 94,938 | +11.0% | 0.00% | 0.0% |
| Q3 2020 | $2,155,000 | +27.7% | 85,554 | +41.5% | 0.00% | 0.0% |
| Q2 2020 | $1,688,000 | +660.4% | 60,448 | +58.5% | 0.00% | – |
| Q1 2020 | $222,000 | -53.2% | 38,137 | -12.5% | 0.00% | – |
| Q4 2019 | $474,000 | +15.6% | 43,565 | +35.6% | 0.00% | – |
| Q3 2019 | $410,000 | -7.9% | 32,137 | +22.4% | 0.00% | – |
| Q2 2019 | $445,000 | -16.2% | 26,261 | -11.3% | 0.00% | – |
| Q1 2019 | $531,000 | +62.9% | 29,618 | +15.4% | 0.00% | – |
| Q4 2018 | $326,000 | -38.1% | 25,668 | +4.4% | 0.00% | – |
| Q3 2018 | $527,000 | -24.6% | 24,578 | -27.5% | 0.00% | -100.0% |
| Q2 2018 | $699,000 | -27.5% | 33,886 | -11.4% | 0.00% | 0.0% |
| Q1 2018 | $964,000 | +42.2% | 38,266 | +7.1% | 0.00% | 0.0% |
| Q4 2017 | $678,000 | -20.1% | 35,742 | -22.2% | 0.00% | 0.0% |
| Q3 2017 | $849,000 | +79.5% | 45,915 | +69.9% | 0.00% | – |
| Q2 2017 | $473,000 | -46.7% | 27,023 | -43.4% | 0.00% | -100.0% |
| Q1 2017 | $887,000 | -26.7% | 47,708 | -19.4% | 0.00% | 0.0% |
| Q4 2016 | $1,210,000 | +11.4% | 59,194 | +63.2% | 0.00% | 0.0% |
| Q3 2016 | $1,086,000 | +24.0% | 36,280 | +11.7% | 0.00% | 0.0% |
| Q2 2016 | $876,000 | +36.9% | 32,479 | -4.9% | 0.00% | 0.0% |
| Q1 2016 | $640,000 | -3.2% | 34,138 | +60.2% | 0.00% | 0.0% |
| Q4 2015 | $661,000 | +97.3% | 21,307 | +36.0% | 0.00% | – |
| Q3 2015 | $335,000 | -85.0% | 15,667 | -73.4% | 0.00% | -100.0% |
| Q2 2015 | $2,232,000 | +151.4% | 58,800 | +108.0% | 0.00% | +100.0% |
| Q1 2015 | $888,000 | -5.5% | 28,263 | +5.4% | 0.00% | 0.0% |
| Q4 2014 | $940,000 | +203.2% | 26,814 | +80.9% | 0.00% | – |
| Q3 2014 | $310,000 | -44.9% | 14,821 | -42.8% | 0.00% | – |
| Q2 2014 | $563,000 | +165.6% | 25,916 | +239.6% | 0.00% | – |
| Q1 2014 | $212,000 | – | 7,631 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 2,115,000 | $37,034,000 | 8.81% |
| INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $18,811,000 | 4.45% |
| DAFNA Capital Management LLC | 119,200 | $2,087,000 | 1.49% |
| BB BIOTECH AG | 2,350,112 | $41,150,000 | 1.26% |
| TIGER MANAGEMENT L.L.C. | 239,667 | $4,197,000 | 0.82% |
| Hood River Capital Management LLC | 576,193 | $10,089,000 | 0.70% |
| Bellevue Group AG | 316,418 | $5,540,000 | 0.66% |
| Rhenman & Partners Asset Management AB | 175,000 | $3,064,000 | 0.44% |
| First Light Asset Management, LLC | 61,538 | $1,078,000 | 0.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 54,000 | $945,000 | 0.36% |